SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 113.04 Million USD | 2.05% |
| 2022 | 110.78 Million USD | -14.51% |
| 2021 | 129.59 Million USD | 99.94% |
| 2020 | 64.81 Million USD | 8.38% |
| 2019 | 59.8 Million USD | 7.7% |
| 2018 | 55.52 Million USD | -15.23% |
| 2017 | 65.5 Million USD | 4.59% |
| 2016 | 62.62 Million USD | -15.88% |
| 2015 | 74.45 Million USD | -19.18% |
| 2014 | 92.12 Million USD | -15.1% |
| 2013 | 108.51 Million USD | 8.8% |
| 2012 | 99.73 Million USD | -7.82% |
| 2011 | 108.19 Million USD | 13.81% |
| 2010 | 95.06 Million USD | 9.81% |
| 2009 | 86.57 Million USD | 5.8% |
| 2008 | 81.82 Million USD | -43.24% |
| 2007 | 144.16 Million USD | 12.35% |
| 2006 | 128.31 Million USD | -6.59% |
| 2005 | 137.37 Million USD | -29.82% |
| 2004 | 195.74 Million USD | -0.35% |
| 2003 | 196.42 Million USD | -5.51% |
| 2002 | 207.89 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 102.84 Million USD | 0.0% |
| 2024 Q1 | 102.84 Million USD | -9.03% |
| 2023 Q1 | 119.82 Million USD | 8.16% |
| 2023 Q3 | 113.04 Million USD | -5.65% |
| 2023 Q4 | 113.04 Million USD | 0.0% |
| 2023 FY | 113.04 Million USD | 2.05% |
| 2023 Q2 | 119.82 Million USD | -0.0% |
| 2022 Q1 | 114.32 Million USD | -11.78% |
| 2022 Q3 | 110.78 Million USD | -3.1% |
| 2022 Q4 | 110.78 Million USD | 0.0% |
| 2022 FY | 110.78 Million USD | -14.51% |
| 2022 Q2 | 114.32 Million USD | 0.0% |
| 2021 Q4 | 129.59 Million USD | 0.0% |
| 2021 Q2 | 95.65 Million USD | 0.0% |
| 2021 Q1 | 95.65 Million USD | 47.59% |
| 2021 FY | 129.59 Million USD | 99.94% |
| 2021 Q3 | 129.59 Million USD | 35.48% |
| 2020 Q1 | 60.55 Million USD | 1.27% |
| 2020 Q4 | 64.81 Million USD | 0.0% |
| 2020 Q2 | 60.55 Million USD | 0.0% |
| 2020 FY | 64.81 Million USD | 8.38% |
| 2020 Q3 | 64.81 Million USD | 7.03% |
| 2019 Q3 | 59.8 Million USD | 12.54% |
| 2019 Q1 | 53.13 Million USD | -4.3% |
| 2019 Q2 | 53.13 Million USD | 0.0% |
| 2019 FY | 59.8 Million USD | 7.7% |
| 2019 Q4 | 59.8 Million USD | 0.0% |
| 2018 Q1 | 67.91 Million USD | 3.68% |
| 2018 FY | 55.52 Million USD | -15.23% |
| 2018 Q4 | 55.52 Million USD | 0.0% |
| 2018 Q3 | 55.52 Million USD | -18.24% |
| 2018 Q2 | 67.91 Million USD | 0.0% |
| 2017 FY | 65.5 Million USD | 4.59% |
| 2017 Q2 | 67.35 Million USD | 0.0% |
| 2017 Q1 | 67.35 Million USD | 7.54% |
| 2017 Q4 | 65.5 Million USD | 0.0% |
| 2017 Q3 | 65.5 Million USD | -2.75% |
| 2016 Q1 | 72 Million USD | 7.71% |
| 2016 FY | 62.62 Million USD | -15.88% |
| 2016 Q4 | 62.62 Million USD | 0.0% |
| 2016 Q3 | 62.62 Million USD | -13.02% |
| 2016 Q2 | 72 Million USD | 0.0% |
| 2015 Q2 | 95.25 Million USD | 4.19% |
| 2015 Q1 | 91.42 Million USD | -0.76% |
| 2015 Q4 | 66.84 Million USD | 0.0% |
| 2015 FY | 74.45 Million USD | -19.18% |
| 2015 Q3 | 66.84 Million USD | -29.82% |
| 2014 Q2 | 106.3 Million USD | -1.75% |
| 2014 Q1 | 108.19 Million USD | -0.3% |
| 2014 FY | 92.12 Million USD | -15.1% |
| 2014 Q4 | 92.12 Million USD | -4.41% |
| 2014 Q3 | 96.38 Million USD | -9.33% |
| 2013 Q4 | 108.51 Million USD | 8.84% |
| 2013 FY | 108.51 Million USD | 8.8% |
| 2013 Q1 | 98.78 Million USD | -0.95% |
| 2013 Q2 | 97.85 Million USD | -0.94% |
| 2013 Q3 | 99.7 Million USD | 1.89% |
| 2012 Q2 | 98.2 Million USD | -10.5% |
| 2012 Q4 | 99.73 Million USD | 2.35% |
| 2012 FY | 99.73 Million USD | -7.82% |
| 2012 Q1 | 109.72 Million USD | 1.42% |
| 2012 Q3 | 97.44 Million USD | -0.78% |
| 2011 Q3 | 112.86 Million USD | 11.0% |
| 2011 Q2 | 101.68 Million USD | 3.22% |
| 2011 Q1 | 98.51 Million USD | 3.62% |
| 2011 FY | 108.19 Million USD | 13.81% |
| 2011 Q4 | 108.19 Million USD | -4.13% |
| 2010 Q4 | 95.06 Million USD | 0.95% |
| 2010 Q1 | 90.66 Million USD | 4.73% |
| 2010 Q2 | 86.9 Million USD | -4.15% |
| 2010 Q3 | 94.17 Million USD | 8.36% |
| 2010 FY | 95.06 Million USD | 9.81% |
| 2009 FY | 86.57 Million USD | 5.8% |
| 2009 Q2 | 81.58 Million USD | 0.0% |
| 2009 Q4 | 86.57 Million USD | 0.0% |
| 2008 FY | 81.82 Million USD | -43.24% |
| 2007 FY | 144.16 Million USD | 12.35% |
| 2006 FY | 128.31 Million USD | -6.59% |
| 2005 FY | 137.37 Million USD | -29.82% |
| 2004 FY | 195.74 Million USD | -0.35% |
| 2003 FY | 196.42 Million USD | -5.51% |
| 2002 FY | 207.89 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accolade, Inc. | 788.15 Million USD | 85.656% |
| Bullfrog AI Holdings, Inc. Common Stock | 2.77 Million USD | -3971.535% |
| BrightSpring Health Services, Inc. Common Stock | 5.79 Billion USD | 98.048% |
| CareCloud, Inc. | 79.51 Million USD | -42.176% |
| CareMax, Inc. | 623.3 Million USD | 81.863% |
| Definitive Healthcare Corp. | 1.82 Billion USD | 93.809% |
| Health Catalyst, Inc. | 701.81 Million USD | 83.892% |
| iCoreConnect Inc. | 15.68 Million USD | -620.681% |
| Inovalon Holdings, Inc. | 1.97 Billion USD | 94.266% |
| Omnicell, Inc. | 2.22 Billion USD | 94.923% |
| Progyny, Inc. | 756.62 Million USD | 85.059% |
| R1 RCM Inc. | 4.96 Billion USD | 97.721% |
| Schrödinger, Inc. | 802.95 Million USD | 85.921% |
| Simulations Plus, Inc. | 196.63 Million USD | 42.509% |
| Streamline Health Solutions, Inc. | 41.74 Million USD | -170.843% |
| SCWorx Corp. | 6.27 Million USD | -1700.666% |
| Sharecare, Inc. | 613.63 Million USD | 81.577% |
| Bullfrog AI Holdings, Inc. Warrants | 2.77 Million USD | -3971.535% |
| SOPHiA GENETICS SA | 206.15 Million USD | 45.163% |
| TruBridge, Inc. | 434.42 Million USD | 73.977% |
| Nutex Health, Inc. | 398.24 Million USD | 71.613% |
| Renalytix Plc | 7.97 Million USD | -1318.084% |
| GE HealthCare Technologies Inc. | 32.45 Billion USD | 99.652% |
| Aclarion, Inc. | 2.45 Million USD | -4495.937% |
| Forian Inc. | 59.37 Million USD | -90.396% |
| HeartBeam, Inc. | 17.13 Million USD | -559.913% |
| GeneDx Holdings Corp. | 473.67 Million USD | 76.133% |
| GoodRx Holdings, Inc. | 1.58 Billion USD | 92.885% |
| HealthEquity, Inc. | 3.23 Billion USD | 96.507% |
| 10x Genomics, Inc. | 965.14 Million USD | 88.287% |
| Zhongchao Inc. | 24.41 Million USD | -363.003% |
| HealthStream, Inc. | 499.94 Million USD | 77.387% |
| Augmedix, Inc. | 66.71 Million USD | -69.459% |
| MSP Recovery, Inc. | 3.15 Billion USD | 96.422% |
| Spok Holdings, Inc. | 227.68 Million USD | 50.348% |
| Privia Health Group, Inc. | 999.9 Million USD | 88.694% |
| EUDA Health Holdings Limited | 1.31 Million USD | -8526.401% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.79 Billion USD | 98.048% |
| Sharecare, Inc. | 613.63 Million USD | 81.577% |
| Premier, Inc. | 3.42 Billion USD | 96.703% |
| Certara, Inc. | 1.56 Billion USD | 92.768% |
| GeneDx Holdings Corp. | 473.67 Million USD | 76.133% |
| Ontrak, Inc. | 19.84 Million USD | -469.635% |
| CareCloud, Inc. | 79.51 Million USD | -42.176% |
| OneMedNet Corporation | 463.05 Thousand USD | -24313.77% |
| HeartBeam, Inc. | 17.13 Million USD | -559.913% |
| EUDA Health Holdings Limited | 1.31 Million USD | -8526.401% |
| CareCloud, Inc. | 79.51 Million USD | -42.176% |
| Mangoceuticals, Inc. | 1.05 Million USD | -10658.51% |
| CareMax, Inc. | 623.3 Million USD | 81.863% |
| Healthcare Triangle, Inc. | 10.04 Million USD | -1024.984% |
| National Research Corporation | 122.43 Million USD | 7.667% |
| Aclarion, Inc. | 2.45 Million USD | -4495.937% |
| OptimizeRx Corporation | 183.37 Million USD | 38.35% |